VYNE Therapeutics Inc. enterprise value

The Enterprise Value as of October 2026 (TTM) for VYNE Therapeutics Inc. (VYNE) is 155.28M

According to VYNE Therapeutics Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 155.28M. This represents a change of -16498.40% compared to the average of -946919.14 of the last 4 quarters.

VYNE Therapeutics Inc. (VYNE) Historical Enterprise Value (quarterly & annually)

How has VYNE Enterprise Value performed in the past?

The mean historical Enterprise Value of VYNE Therapeutics Inc. over the last ten years is 175.97M. The current 155.28M Enterprise Value has changed -11.76% with respect to the historical average. Over the past ten years (40 quarters), VYNE's Enterprise Value was at its highest in in the December 2016 quarter at 32.98B. The Enterprise Value was at its lowest in in the December 2022 quarter at -22848635.00.

VYNE Therapeutics Inc. (VYNE) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of VYNE Therapeutics Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

VYNE Therapeutics Inc. (VYNE) Average Enterprise Value

How has VYNE Enterprise Value performed in the past?

The current Enterprise Value of VYNE Therapeutics Inc. (VYNE) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

VYNE Therapeutics Inc. (VYNE) Enterprise Value vs. Peers

How is VYNE’s Enterprise Value compared to its peers?

VYNE Therapeutics Inc.’s Enterprise Value is greater than AIM ImmunoTech Inc. (599.65K), greater than KALA BIO, Inc. (3.14M), greater than Pasithea Therapeutics Corp. (-33290412.00), greater than Soligenix, Inc. (-1640331.00), greater than Alaunos Therapeutics, Inc. (6.43M), greater than Brainstorm Cell Therapeutics Inc. (10.62M), greater than Quoin Pharmaceuticals, Ltd. (4.85M), greater than Ensysce Biosciences, Inc. (7.40M), greater than XTL Biopharmaceuticals Ltd. (4.58M), greater than Matinas BioPharma Holdings, Inc. (-332192.00),

Build a custom stock screener for VYNE Therapeutics Inc. (VYNE) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like VYNE Therapeutics Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

VYNE Therapeutics Inc. (VYNE) and other stocks custom spreadsheet templates

The easiest way to analyze a company like VYNE Therapeutics Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.